Spektus is a specialty pharmaceutical company dedicated to developing and delivering value-added medicines for the Central Nervous System (CNS) segment. Our portfolio addresses unmet needs in depression, ADHD, and pain, with a pipeline of differentiated oral drugs built using our proprietary drug-delivery platforms. At the heart of our innovation is Flexitab®, a patented breakable extended-release platform that enables clinically meaningful benefits and new label opportunities for established molecules. Headquartered in Laval, Quebec, Spektus operates its own R&D facilities and partners globally with leading pharmaceutical companies, with a primary focus on the North American and European markets.
| Website | http://www.spektuspharma.com |
| Employees | 6 (3 on RocketReach) |
| Founded | 2024 |
| Address | 500 Boulevard Cartier Ouest, Laval, Quebec H7V 5B7, CA |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Unmet Medical Needs, Innovative Medicines, Novel Therapeutics, Pharmaceutical Research, Pharmaceutical Portfolio, Drug Development, New Drug Applications, Clinical Trials, Drug Discovery, Biopharmaceutical, Fda Approval, Prescription Drugs, Health Care, Patient Care |
Looking for a particular Spektus Pharma employee's phone or email?
Spektus Pharma Questions
Zarvaan Merchant is the CEO of Spektus Pharma.
3 people are employed at Spektus Pharma.
Spektus Pharma is based in Laval, Quebec.
Top Spektus Pharma Employees
-
Zarvaan Merchant
Chief Executive Officer at Spektus Pharma
United Arab Emirates12 -
11
-
Marc Lemieux
V.P., Product Development at Spektus Pharma
Montreal, QC, CA
